Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Ultivue Inc. is raising $26,502,993.00 in a new round of investment. Sources indicate as part of senior management President, Michael Natan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Ultivue Inc.

Ultivue develops innovative reagent-based solutions that maximize the biological information available from cells and tissue samples. The company’s technology is being used to elucidate biological pathways and to validate clinically-relevant biomarkers.

To learn more about Ultivue Inc., visit http://www.ultivue.com/

Contact:
Michael Natan, President
781-883-1531
michael.natan@ultivue.com
https://www.linkedin.com/in/michael-natan-5b73113/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved